FDA Approved: REBLOZYL — Supplemental Application (Celgene Corporation)

View source ↗

Summary

FDA approved a supplemental application for Reblozyl (luspatercept) by Celgene Corporation. The action concerns updating the product's labeling/indication via a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Myelodysplastic Syndrome

Drugs mentioned

• REBLOZYL (LUSPATERCEPT)

Snippet

SUPPL AP for REBLOZYL (LUSPATERCEPT)